title: Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
authors.affiliation: Multiple Sclerosis Center at Texas Neurology, Dallas, TX, USA JTPhillips@TexasNeurology.com.
authors.forename: J Theodore
authors.initials: JT
authors.lastname: Phillips
authors.forename: Elliot M
authors.initials: EM
authors.lastname: Frohman